New SEC Form D filing
Epicrispr Biotechnologies, Inc., 2026-08-26
A new SEC Form D private-offering notice from South San Francisco, CA, a $212,755,230 filer-stated offering target in Biotech. The source filing is one click away.
What this filing says
Epicrispr Biotechnologies, Inc. Verified via SEC Form D
Filed 2026-08-26Filed to raise $212,755,230First money in 2018-05-04Raised so far $176,754,406HQ (as filed) South San Francisco, CASector Biotech machine-classified from the filing aloneStage (inferred) LateCall status Late filing
Source linked the Form D on EDGAR↗Named in the filing 7 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Databricks, Inc., 2026-08-27, $5B, San Francisco, CA
- UBIVAC, INC., 2026-08-27, Portland, OR
- Genesys Cloud Services Topco LLC, 2026-08-27, $25M, Menlo Park, CA
- Noveome Biotherapeutics, Inc., 2026-08-27, $15M, Pittsburgh, PA
- Symosphere Inc., 2026-08-26, $200K, San Diego, CA
- FluidForm Bio, Inc., 2026-08-27, $3M, Waltham, MA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.